Front Street Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-423
Closed -$122K 73
2023
Q4
$122K Sell
423
-42
-9% -$11.4K 0.02% 83
2023
Q3
$125K Buy
+465
New +$116K 0.03% 77
2020
Q1
Sell
-885
Closed -$213K 54
2019
Q4
$213K Buy
+885
New +$195K 0.06% 58
2019
Q2
Sell
-1,450
Closed -$275K 61
2019
Q1
$275K Sell
1,450
-25
-2% -$4.77K 0.07% 52
2018
Q4
$287K Sell
1,475
-125
-8% -$24.4K 0.09% 54
2018
Q3
$332K Sell
1,600
-115
-7% -$22.7K 0.11% 52
2018
Q2
$317K Buy
1,715
+240
+16% +$42.5K 0.12% 50
2018
Q1
$251K Hold
1,475
0.1% 51
2017
Q4
$257K Sell
1,475
-26
-2% -$4.6K 0.09% 54
2017
Q3
$280K Hold
1,501
0.1% 52
2017
Q2
$259K Hold
1,501
0.1% 55
2017
Q1
$246K Hold
1,501
0.1% 60
2016
Q4
$250K Hold
1,501
0.12% 54
2016
Q3
$250K Sell
1,501
-11
-0.7% -$1.86K 0.12% 55
2016
Q2
$230K Buy
+1,512
New +$235K 0.11% 58

Other funds holding AMGN

Front Street Capital Management's AMGN Position: Q1 2024 in Review

Front Street Capital Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 423 shares — an estimated $122K sold.

Front Street Capital Management first reported a position in AMGN in Q2 2016 and held it in 15 quarters. The position peaked at $332K in Q3 2018. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Front Street Capital Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Front Street Capital Management sold 423 Amgen shares in Q1 2024, an estimated $122K.
  • Front Street Capital Management first reported a position in Amgen in Q2 2016 and held it in 15 quarters.
  • Front Street Capital Management's Amgen position peaked at $332K in Q3 2018.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Front Street Capital Management's 13F filing for Q1 2024, filed 14 May 2024.